title: Primary aldosteronism and low-renin hypertension: a continuum?
authors.affiliation: Prince Henry's Institute, PO Box 5152, Clayton, VIC 3168, Australia. john.funder@princehenrys.org
authors.forename: John W
authors.initials: JW
authors.lastname: Funder
mesh_terms: D000075222:Essential Hypertension; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications*; D006973:Hypertension / Q000150:complications*; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D012083:Renin / Q000378:metabolism*; D013148:Spironolactone / Q000627:therapeutic use*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D012083:Renin
keywords: aldosterone–renin ratio; between-patient variability; low-renin hypertension; mineralocorticoid receptors; primary aldosteronism